RGD-DA6
RGD-DA6 is an αvβ3-targeted ligand. RGD-DA6 consists of RGDfK (an integrin αvβ3-targeted RGD peptide), DOTADG, d-Glu, Lys, AMBA, and IPBA. RGD-DA6 can be radiolabeled as an αvβ3-targeted radioligand and used for high-contrast tumor imaging and enhanced anticancer efficacy[1].
Product Specifications
UNSPSC
12352005
Target
Integrin
Related Pathways
Cytoskeleton
Field of Research
Cancer
Smiles
O=C(NCCCC[C@@H]1NC([C@H](NC([C@@H](NC(CNC([C@@H](NC1=O)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC2=CC=CC=C2)=O)CCC(N(CCN(CC3)CC(O)=O)CCN(CC(O)=O)CCN3C(CCC(N[C@@H](C(N[C@@H](CCCCNC(C4=CC=C(C=C4)CNC(CCCC5=CC=C(C=C5)I)=O)=O)C(O)=O)=O)CCC(O)=O)=O)C(O)=O)C(O)=O
Molecular Formula
C78H110IN17O24
Molecular Weight
1796.71
References & Citations
[1]Kazuta N, et al. Development of Novel Integrin αvβ3‑Targeted Radioligand for Enhanced Tumor Accumulation. ACS Med Chem Lett. 2025 Jun 30;16 (7) :1346-1353.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470994-100 1x 100 µL
TNF alpha (J2D10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470775-500 1x 500 µL
Pgp9.5 (UCHL-1) (UCHL1/775), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941101-100 1x 100 µL
MCAM / MUC18 / Mucin 18 / CD146 (MCAM/1101), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940952-100 1x 100 µL
Human IgG Immunoglobulin (B33/20), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details